Reflecting on PEGS Europe 2023
Drug Discovery World
NOVEMBER 30, 2023
Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. GSK has developed high-throughput mammalian and E. To demonstrate the utility of the company’s SYNTAX system in gene assembly, the 1.7
59 
Let's personalize your content